Published in Infect Immun on June 01, 1998
An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med (2002) 2.25
Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother (2008) 2.02
Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91
Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun (1999) 1.50
Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther (2014) 1.48
The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med (2008) 1.20
Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun (2003) 1.10
Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect Immun (2000) 1.09
Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins. Infect Immun (2002) 1.05
Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl. J Bacteriol (2000) 1.02
Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun (2007) 1.01
Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3. Infect Immun (2006) 1.01
Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi. Infect Immun (2000) 0.95
Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients. Infect Immun (2001) 0.95
Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM. Infect Immun (2012) 0.94
Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infect Immun (2011) 0.94
Adenoviral delivery of interleukin-10 fails to attenuate experimental Lyme disease. Infect Immun (2008) 0.90
Lipoprotein-dependent and -independent immune responses to spirochetal infection. Clin Diagn Lab Immunol (2005) 0.90
Infectivity of the highly transformable BBE02- lp56- mutant of Borrelia burgdorferi, the Lyme disease spirochete, via ticks. Infect Immun (2006) 0.86
Borrelia burgdorferi promotes the establishment of Babesia microti in the northeastern United States. PLoS One (2014) 0.84
Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice. PLoS One (2012) 0.84
Early cytokine release in response to live Borrelia burgdorferi Sensu Lato Spirochetes is largely complement independent. PLoS One (2014) 0.76
Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis. J Transl Med (2015) 0.76
The Cross-Talk between Spirochetal Lipoproteins and Immunity. Front Immunol (2014) 0.76
Spirochetal Lipoproteins and Immune Evasion. Front Immunol (2017) 0.75
Differentiated THP-1 Cells Exposed to Pathogenic and Nonpathogenic Borrelia Species Demonstrate Minimal Differences in Production of Four Inflammatory Cytokines. Vector Borne Zoonotic Dis (2016) 0.75
The immunological response to syphilis differs by HIV status; a prospective observational cohort study. BMC Infect Dis (2017) 0.75
Role of adrenomedullin in Lyme disease. Infect Immun (2010) 0.75
Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis. Infect Immun (2013) 0.75
Induction of Experimental Arthritis by Borrelial Lipoprotein and CpG Motifs: Are Toll-Like Receptors 2, 4, 9 or CD-14 Involved? Open Rheumatol J (2011) 0.75
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol (1991) 11.04
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med (1996) 5.46
Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry (1976) 5.43
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol (1993) 4.65
Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol (1991) 4.59
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med (1994) 4.07
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81
Chronic lyme disease in the rhesus monkey. Lab Invest (1995) 2.30
Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif (1990) 2.23
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun (1993) 2.18
Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun (1991) 2.13
Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect Immun (1993) 2.11
Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins. Proc Natl Acad Sci U S A (1996) 1.90
Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol (1995) 1.86
Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Infect Immun (1993) 1.79
Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun (1996) 1.71
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun (1994) 1.66
In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun (1992) 1.55
Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun (1999) 1.50
Comparative sequence analysis of cytokine genes from human and nonhuman primates. J Immunol (1995) 1.48
Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. J Clin Invest (1992) 1.45
Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun (1994) 1.45
Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur J Immunol (1990) 1.41
Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun (1994) 1.40
Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood. Arthritis Rheum (1986) 1.31
T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J Immunol (1995) 1.26
Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms. Semin Arthritis Rheum (1989) 1.25
Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection (1996) 1.24
T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum (1997) 1.23
Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis (1991) 1.16
Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Immunol Lett (1994) 1.04
A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology (1994) 1.02
Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi. J Infect Dis (1993) 1.00
Modulation of natural killer cell activity by Borrelia burgdorferi. Ann N Y Acad Sci (1988) 0.98
Cellular immune response in Lyme disease: the response to mitogens, live Borrelia burgdorferi, NK cell function and lymphocyte subsets. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.98
Cellular immune findings in Lyme disease. Correlation with serum IgM and disease activity. Am J Med (1984) 0.96
Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy. Cytokine (1996) 0.95
Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear cells. Cytokine (1993) 0.94
Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J Infect Dis (1994) 0.92
Simultaneous measurement by flow cytometry of phagocytosis and metabolic burst induced in phagocytic cells in whole blood by Borrelia burgdorferi. FEMS Microbiol Lett (1994) 0.91
Antigens of Lyme disease of spirochaete Borrelia burgdorferi inhibits antigen or mitogen-induced lymphocyte proliferation. FEMS Immunol Med Microbiol (1994) 0.84
Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol (1999) 3.41
Chronic lyme disease in the rhesus monkey. Lab Invest (1995) 2.30
Cell-density-dependent expression of Borrelia burgdorferi lipoproteins in vitro. Infect Immun (1997) 2.19
Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect Immun (1993) 2.11
An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J Immunol (1999) 2.09
Differential expression of Borrelia burgdorferi proteins during growth in vitro. Infect Immun (1998) 1.96
Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect Immun (1994) 1.55
Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect Immun (1999) 1.53
Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun (1999) 1.50
Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J Infect Dis (2000) 1.45
Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 1.41
C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infect Immun (2001) 1.37
Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector. Infect Immun (2001) 1.32
Host DNA can interfere with detection of Borrelia burgdorferi in skin biopsy specimens by PCR. J Clin Microbiol (1996) 1.27
The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine (1997) 1.21
The lesions and prevalence of Trypanosoma cruzi in opossums and armadillos from southern Louisiana. J Parasitol (1991) 1.20
Serologic and blood culture survey of Trypanosoma cruzi infection in four canine populations of southern Louisiana. Am J Vet Res (1991) 1.18
CD19(+) cells produce IFN-gamma in mice infected with Borrelia burgdorferi. Eur J Immunol (2001) 1.11
Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host species. Infect Immun (2000) 1.09
Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect Immun (2000) 1.09
Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis (1998) 1.07
Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol (1997) 1.05
Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl. J Bacteriol (2000) 1.02
C-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi. Infect Immun (2001) 1.02
Detection of serum IgG antibodies specific for Wolbachia surface protein in rhesus monkeys infected with Brugia malayi. J Infect Dis (2001) 1.01
Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement. Infect Immun (1999) 1.01
Brugia pahangi: effects of duration of infection and parasite burden on lymphatic lesion severity, granulomatous hypersensitivity, and immune responses in jirds (Meriones unguiculatus). Exp Parasitol (1990) 1.00
Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi. Infect Immun (2000) 0.95
DNA-Binding proteins possibly involved in regulation of the post-logarithmic-phase expression of lipoprotein P35 in Borrelia burgdorferi. J Bacteriol (2000) 0.90
Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis (2004) 0.89
Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present. Infect Immun (1998) 0.88
Lyme neuroborreliosis in the rhesus monkey. Semin Neurol (1997) 0.87
Transcriptional regulation in spirochetes. J Mol Microbiol Biotechnol (2000) 0.85
Borrelia burgdorferi possesses a collagenolytic activity. FEMS Microbiol Lett (1996) 0.82
Cellular immune responses of jirds to extracts of life cycle stages and adult excretory secretory products during the early development of Brugia pahangi. Exp Parasitol (1996) 0.81
Brugia malayi: the diagnostic potential of recombinant excretory/secretory antigens. Exp Parasitol (1994) 0.80
Dirofilaria immitis: ultrastructural localization, molecular characterization, and analysis of the expression of p27, a small heat shock protein homolog of nematodes. Exp Parasitol (1996) 0.79
Infections of inbred mice with three Trypanosoma cruzi isolates from Louisiana mammals. J Parasitol (1990) 0.78
Leishmania donovani: clinical, hematologic and hepatic changes in squirrel monkeys (Saimiri sciureus). J Parasitol (1985) 0.78
Positive IgG Western blot for Borrelia burgdorferi in Colombia. Mem Inst Oswaldo Cruz (1999) 0.78
Growth characteristics in axenic and cell cultures, protein profiles, and zymodeme typing of three Trypanosoma cruzi isolates from Louisiana mammals. J Parasitol (1990) 0.77
Diminished production of T helper 1 cytokines and lack of induction of IL-2R+ T cells correlate with T-cell unresponsiveness in rhesus monkeys chronically infected with Brugia malayi. Exp Parasitol (1998) 0.77
Effects of repeated Strongylus vulgaris inoculations and concurrent ivermectin treatments on mesenteric arterial lesions in pony foals. Am J Vet Res (1990) 0.76
Leishmania braziliensis: development of primary and satellite lesions in the experimentally infected owl monkey, Aotus trivirgatus. Exp Parasitol (1986) 0.76
Leishmania donovani: cellular and humoral immune responses after primary and challenge infections in squirrel monkeys, Saimiri sciureus. Exp Parasitol (1986) 0.76
Blastogenic responses of peripheral blood leukocytes from owl monkeys experimentally infected with Leishmania braziliensis panamensis. Am J Trop Med Hyg (1986) 0.76
Expression and characterization of a multivalent human respiratory syncytial virus protein. Mol Biol (Mosk) (2010) 0.76
Atomic force microscopic investigation of respiratory syncytial virus infection in HEp-2 cells. J Microsc (2013) 0.75
Antibody and lymphoblastogenic responses of dogs experimentally infected with Trypanosoma cruzi isolates from North American mammals. Vet Immunol Immunopathol (1991) 0.75
Clinical outcome of a protocol to produce immunosuppression in rhesus monkeys (Macaca mulatta): application to infectious disease and gene therapy studies. J Med Primatol (1999) 0.75
Borrelia burgdorferi stimulates in vitro a selective expansion of CD3-CD4-CD8- (triple negative) autoreactive cells in naive rhesus monkey lymphocytes. J Infect Dis (2001) 0.75
Protection of yearling ponies against Strongylus vulgaris by foalhood vaccination. Equine Vet J Suppl (1989) 0.75
Swift identification of recombinant proteins from lambda-phage libraries without resorting to liquid cultures or lysogens. Biotechniques (1993) 0.75
Leishmania braziliensis in the squirrel monkey: development of primary and satellite lesions and lack of cross-immunity with Leishmania donovani. J Parasitol (1990) 0.75
Antibody responses, as measured by the enzyme-linked immunosorbent assay (ELISA), in owl monkeys experimentally infected with Leishmania braziliensis panamensis. J Parasitol (1987) 0.75
Diminished expression of the costimulatory ligand CD80 (B7.1) gene correlates with antigen-specific cellular unresponsiveness in rhesus monkeys with lymphatic filariasis. Acta Trop (2001) 0.75
Role of the eosinophil in serum-mediated adherence of equine leukocytes to infective larvae of Strongylus vulgaris. J Parasitol (1992) 0.75